FINRA Matters. FINRA shall have confirmed that it has not raised any objection with respect to the fairness and reasonableness of the underwriting terms and arrangements.
Appears in 57 contracts
Sources: Underwriting Agreement (MEDI Group LTD), Underwriting Agreement (MEDI Group LTD), Underwriting Agreement (MEDI Group LTD)
FINRA Matters. FINRA The Financial Industry Regulatory Authority (“FINRA”) shall have confirmed that it has not raised any objection with respect to the fairness and reasonableness of the underwriting placement agency terms and arrangements.
Appears in 13 contracts
Sources: Placement Agency Agreement (xG TECHNOLOGY, INC.), Placement Agency Agreement (xG TECHNOLOGY, INC.), Placement Agency Agreement (SANUWAVE Health, Inc.)
FINRA Matters. FINRA shall shall, if applicable, have confirmed that it has not raised any objection with respect to the fairness and reasonableness of the underwriting terms and arrangements.
Appears in 6 contracts
Sources: Underwriting Agreement (Biomarin Pharmaceutical Inc), Underwriting Agreement (Biomarin Pharmaceutical Inc), Underwriting Agreement (Biomarin Pharmaceutical Inc)
FINRA Matters. FINRA shall have confirmed that it has not raised any objection with respect to the fairness and reasonableness of the underwriting placement agency terms and arrangements.
Appears in 3 contracts
Sources: Placement Agency Agreement (Sphere 3D Corp), Placement Agency Agreement (Pharmathene, Inc), Placement Agency Agreement (Chelsea Therapeutics International, Ltd.)
FINRA Matters. FINRA shall have confirmed that it has not raised any objection objections with respect to the fairness and reasonableness of the underwriting terms and arrangements.
Appears in 3 contracts
Sources: Underwriting Agreement (Ambitions Enterprise Management Co. L.L.C), Underwriting Agreement (OTSAW LTD), Underwriting Agreement (Ambitions Enterprise Management Co. L.L.C)